F. Ionna

Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: A phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG) (2000)

Caponigro, F., Cornelia, P., Rivellini, F., Avallone, A., Budillon, A., Di Gennaro, E., ...

Background: The combination of cisplatin (CDDP) and 5-fluorouracil (5-FU) can be regarded as a reference regimen in squamous cell carcinoma of the head and neck (SCCHN). Raltitrexed (Tomudex) is a...

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer (2000)

Caponigro, F., Cornelia, P., Budillon, A., Bryce, J., Avallone, A., De Rosa, V., ...

Background: Pegylated liposome technology represents a favourable drug-carrier system, since stealth liposomal drugs have a reduced clearance with prolonged circulation half-life and selective drug...

Role of sentinel lymph node biopsy in oral cancer

Calabrese, L, Bruschini, R, Ansarin, M, Giugliano, G, De Cicco, C, Ionna, F, ...

Squamous cell carcinoma of the oral cavity represents about 2% of all malignant neoplasms and 47% of those developing in the head and neck area. The tongue is the most common site involved, and this...